ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 928,97
-0,86%
Dow Jones
38 571,03
-0,30%
DAX
18 385,95
-1,21%
Brent Oil
77,145
-1,27%
Bitcoin
68 920,07
0,17%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Nexmed (MM) (NEXM)

  7. Nexmed (MM) (NEXM) Actualités

NEXM

Nexmed (MM) (NEXM)

Nexmed (MM)
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:NEXM
DateHeureSourceTitreSymboleSociété
10/09/201023h11Edgar (US Regulatory)Current report filing (8-K)NASDAQ:NEXMNexmed (MM)
10/09/201022h31Business WireNexMed, Inc. Announces Results of Special Meeting of Stockholders, Including Name Change to Apricus BiosciencesNASDAQ:NEXMNexmed (MM)
31/08/201023h18Edgar (US Regulatory)Securities Registration Statement (S-1)NASDAQ:NEXMNexmed (MM)
25/08/201017h00Business WireNexMed To Present at the Rodman & Renshaw 12th Annual Healthcare ConferenceNASDAQ:NEXMNexmed (MM)
23/08/201015h00Business WireNexMed Receives Additional Patent Coverage for IsraelNASDAQ:NEXMNexmed (MM)
17/08/201012h03Edgar (US Regulatory)Proxy Statement (definitive) (DEF 14A)NASDAQ:NEXMNexmed (MM)
12/08/201023h10Edgar (US Regulatory)Quarterly Report (10-Q)NASDAQ:NEXMNexmed (MM)
11/08/201015h15Business WireNexMed Announces 2010 Second Quarter Financial Results Conference CallNASDAQ:NEXMNexmed (MM)
06/08/201020h34Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (PRE 14A)NASDAQ:NEXMNexmed (MM)
26/07/201018h36Business WireMohamed Hachicha, Ph.D. Joins NexMed, Inc. as Vice President-Research and Development for NexMed, USANASDAQ:NEXMNexmed (MM)
21/06/201015h15GlobeNewswire Inc.Emerging Stock Report Initiates Independent Research Coverage on NexMed, Inc.NASDAQ:NEXMNexmed (MM)
15/06/201020h48Business WireNexMed Announces Pre-Clinical Results Showing That Its Proprietary Calcipotriene Betamethasone Psoriasis Formulation is Bioeq...NASDAQ:NEXMNexmed (MM)
10/06/201019h30Business WireNexMed Provides Update on Canadian Filing for Vitaros®NASDAQ:NEXMNexmed (MM)
27/05/201000h24Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NEXMNexmed (MM)
25/05/201023h00Business WireNexMed Announces Expansion of Senior Business Development TeamNASDAQ:NEXMNexmed (MM)
17/05/201023h11Business WireNexMed to Discuss P2/3 Protocol for NexACT®-Based Alprostadil Treatment for Raynaud’s Syndrome with the FDANASDAQ:NEXMNexmed (MM)
12/05/201022h30Business WireNexMed Announces Pre-Clinical Study Showing Vitaros® Significantly Promotes Wound HealingNASDAQ:NEXMNexmed (MM)
10/05/201023h19Business WireNexMed Announces Encouraging Pre-Clinical Results Showing the Ability of the NexACT® Technology to Enhance the Bioavailabili...NASDAQ:NEXMNexmed (MM)
07/05/201011h50GlobeNewswire Inc.BioTech Stock Alert for NexMed Inc. Issued by MicroStockProfitNASDAQ:NEXMNexmed (MM)
06/05/201022h45Business WireNexMed Expands Scientific Advisory Board with Appointment of Key Industry LeadersNASDAQ:NEXMNexmed (MM)
05/05/201022h36Business WireNexMed Announces Patent Allowance for NexACT® in CanadaNASDAQ:NEXMNexmed (MM)
30/04/201020h53Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (DEFA14A)NASDAQ:NEXMNexmed (MM)
29/04/201000h47Business WirePre-Clinical Results Show NexACT® Technology Significantly Improves Subcutaneous Delivery & Anti-Metastatic Activity of Angs...NASDAQ:NEXMNexmed (MM)
27/04/201022h40Business WireNexMed Appoints Dr. Stephen B. Howell, World Renowned Key Opinion Leader in Oncology as Chairman of Its Scientific Advisory B...NASDAQ:NEXMNexmed (MM)
27/04/201014h30MarketwiredMarket Pulse Breaking News Alert for Tuesday, April 27, 2010: MZEI -- Implications of Test Results Are Enormous to Medizone as tNASDAQ:NEXMNexmed (MM)
26/04/201022h45Business WireNexMed Receives FDA Clearance for PrevOnco™ Phase 2 Study as First-Line Therapy for HCCNASDAQ:NEXMNexmed (MM)
23/04/201002h50Business WireNexMed Files CMC Response with Health Canada for Vitaros®NASDAQ:NEXMNexmed (MM)
21/04/201023h24Edgar (US Regulatory)Prospectus filed pursuant to Rule 424(b)(5) (424B5)NASDAQ:NEXMNexmed (MM)
20/04/201012h02Edgar (US Regulatory)Prospectus filed pursuant to Rule 424(b)(3) (424B3)NASDAQ:NEXMNexmed (MM)
19/04/201012h00Edgar (US Regulatory)Notice of Effectiveness (EFFECT)NASDAQ:NEXMNexmed (MM)
 Showing the most relevant articles for your search:NASDAQ:NEXM

Dernières Valeurs Consultées

EU
BNP
BNP Paribas
EU
LR
Legrand
NYSE
KO
Coca Cola
EU
RI
Pernod Ricard
EU
VK
Vallourec
NYSE
MCD
McDonalds
EU
GLE
Societe Generale
NYSE
MRK
Merck
NYSE
JPM
JP Morgan Chase
COIN
ETHUSD
Ethereum
EU
CS
Axa
NYSE
NKE
Nike
NASDAQ
GOOGL
Alphabet
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés